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Abstract
Iron oxides in macro/mesoporous bioactive glasses were
characterized by synchrotron X-ray absorption near edge
structure (XANES) spectroscopy. This magnetic phase was
introduced by adding Fe(NO3)3 9H2O during the sol-gel
synthesis. The obtained bioactive glass scaffolds exhibited
superparamagnetism, in which the magnetization was
increased with the increase in the Fe molar ratio from 10 to
20%. The linear combination fits of the XANES spectra
indicated that the increase in the Fe molar ratio to 20%
enhanced the γ-Fe2O3 formation at the expense of the α-
Fe2O3 phase. This variation also promoted the formation of
fine-grained bone-like apatites on the surface of the
scaffolds in the in vitro test. The apatite growth between
three and seven days was confirmed by the changing
elemental compositions. However, the highest magnetic
proportion led to the distortion of the skeleton walls and
the collapse of the porous networks.
Keywords Macro/mesoporous Bioactive Glass, Sol-gel
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1. Introduction
Porous bioactive glass scaffolds have been under research
and development for the regeneration of bone defects [1,
2]. Their bioactivity and biodegradability are vastly
enhanced compared with traditional bioactive glasses, due
to large surface areas in the mesostructures [3, 4]. More‐
over, in vitro tests on bioactive glasses combined with other
phases have been reported [5, 6]. By incorporating mag‐
netic nanoparticles, the obtained bioactive glasses can be
implemented in local hyperthermia treatments. In response
to alternating magnetic fields, heat is generated to eliminate
cancerous tissues around the bone defects [7–9]. Local drug
delivery can also be added to prevent the transportation of
cancer cells to other sites [9–11]. To realize the commercial
potential of these multifunctional bioactive glasses,
attempts have been made to determine the influence of
process parameters on the distribution of pores, magnetic
properties and bioactivity.
Magnetic bioactive glasses have mostly been obtained from
the sol-gel synthesis [10, 12–14]. The sizes of the macro‐
pores are commonly between 200 and 500 μm, whereas the
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average diameter of the mesopores is in the range of 3-5 nm
[8, 9, 13]. Interestingly, X. Li et al. reported a reduction in
pore size of CaO-P2O5-SiO2/Fe3O4 glass with an increase in
Ca concentrations and a decrease in Fe concentrations [11].
From the point of view of application, the biocompatibility
of macro/mesoporous bioactive glasses with a magnetic
phase was tested and confirmed [8–10, 12, 13]. The growth
of apatites in the in vitro test is one of the common indicators
of bioactivity. However, it is observed that the apatite-
forming ability and cell attachment tend to decrease with
an increase in the magnetic phase in bioactive glasses [15].
In addition to bioactivity tests, the capability of the drug
loading-release was also demonstrated [9, 11, 13].
Superparamagnetic properties of bioactive glass scaffolds
are reportedly attributed to different forms of iron oxides
added during the synthesis or formed in the calcination
step. For example, magnetite (Fe3O4) nanoparticles are
distributed in the walls between mesopores in the works of
Wang et al. [8] and Li et al. [11], whereas a maghemite (γ-
Fe2O3) phase was detected by M. Zhu et al. [13]. In addition
to these iron oxides, manganese ferrite [12] and zinc ferrite
[16] were successfully introduced as a soft magnetic phase
with a narrow hysteresis loop and low coercivity in a
bioactive glass matrix. Furthermore, a mixed phase with
more than one type of magnetic nanoparticles may be
obtained [17].
In this work, bioactive glass scaffolds are magnetically
tuned by varying the molar ratios of iron in the synthesis
and the effect of the magnetic phase on bioactivity is
investigated. In addition to elemental composition and
magnetic measurements, synchrotron X-ray absorption
near edge structure (XANES) spectra are analysed to study
the mixed iron oxide phase, which contributes to the
desirable bioactivity and magnetic properties for imple‐
mentations.
2. Materials and Methods
Magnetic bioactive glass scaffolds were synthesized by
using the one-pot sol-gel method. Four samples, i.e.,
65S10Fe, 65S15Fe, 65S20Fe and 60S20Fe, were obtained
from varying compositions of starting reagents listed in
Table 1. Poly-methyl methacrylate (PMMA) colloidal
crystals were used as the three-dimensionally ordered
macroporous (3DOM) structure template. Poly(ethylene
glycol)-block-poly(propylene glycol)-block-poly(ethylene
glycol) (P123) acted as both the mesoporous structure-
directing agent and the reducing agent for Fe. Solutions of
P123, Ca(NO3)2 4H2O and Fe(NO3)3 9H2O in ethanol were
gradually added drop-by-drop and mixed with tetraethyl
orthosilicate (TEOS), triethyl phosphate (TEP) and NaNO3.
The solution was vigorously stirred (∼700 rpm) at room
temperature and HNO3 was added as the catalyst. The
stirring was terminated when the solution reached the gel
point and the PMMA colloidal crystals were soaked in the
solution. The excess solution was removed after the
complete immersion. The samples were aged in the sealed
vials at 45° C for one day, allowing a continuous polycon‐
densation reaction. They were then dried at 45° C for one
day to eliminate excess solutions. Finally, the dried samples
were calcined at 600° C for 6 h with a heating rate of 2°
C/min and a cooling rate of 20° C/min.
The calcined samples were characterized for their physical
properties and bioactivity. The field emission scanning
electron microscope (FESEM: Zeiss Supra 55VP), operated
at 20 kV, gave details of the structure, size and shape of the
skeleton walls and the windows between the macropores.
Each sample was coated with a conductive carbon layer to
prevent charge accumulation. The energy dispersive
spectrometry (EDS: Zeiss Evo LS15 with a Bruker EDS
Quantax 400) with the detectors attached to the FESEM was
used to determine the elemental compositions of the
scaffolds. To identify the structure of the magnetic phase,
the XANES spectra were measured at BL-8 Synchrotron
Light Research Institute, Thailand. Samples were prepared
by grinding dried powder in a mortar to reduce the grain
size. They were then thinly dispersed on the substrate and
covered by polyimide tape. The Fe K-edge spectra were
collected at room temperature in the fluorescent mode with
ionization chambers and 13-array Ge detectors placed
before and on the left-hand side of the sample. In the
measurement, the photon energy was scanned from -100
eV below the edge to 300 eV above the edge by a Ge(220)
double crystal monochromator. For the linear combination
fitting (LCF), Fe, FeO, Fe3O4, γ-Fe2O3, and α-Fe2O3 stand‐
ards were also measured as references. The XANES spectra
were normalized after pre-edge and post-edge subtractions
and fitted using the Athena program [18].
To examine the magnetic properties at room temperature,
the magnetizations of the bioactive glass scaffolds in
response to the varying magnetic fields between -10 kOe






















65S10Fe 65-15-5-5-10 0.542 1.46 0.15 1.00 0.354 0.404 1.00 2.50
65S15Fe 65-10-5-5-15 0.543 1.46 0.15 1.00 0.237 0.607 1.00 2.50
65S20Fe 65-5-5-5-20 0.542 1.46 0.15 1.00 0.118 0.808 1.00 2.50
60S20Fe 60-10-5-5-20 0.506 1.34 0.15 1.00 0.236 0.809 1.00 2.50
Table 1. Composition of reagents used in the sol-gel synthesis of magnetic bioactive glass scaffolds
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magnetometry (VSM). In the in vitro bioactivity test at body
temperature (37° C) using the Kokubo method [19], the
samples 65S15Fe and 60S20Fe were immersed in the
stimulated body fluid (SBF), whose composition and ionic
concentration similar to human blood plasma was detailed
in the previous report [20]. The formation of the apatite
phase was monitored by FESEM after a half, one, three and
five days. For the samples after three and seven days, X-ray
diffractometry (XRD) was carried out by Philips X’Pert
using Cu Kα radiation in the 2θ range of 10-50 degrees with
2 degrees/min for each step.
3. Results and Discussion
The variation in magnetization of each bioactive glass
scaffold in response to an applied magnetic field, as shown
in Figure 1, confirms that the magnetic phase is successfully
introduced. The magnetization, induced in the direction of
the increasing magnetic field up to 10 kOe, is enhanced by
the increase in Fe(NO3)3 9H2O from 10 to 20% mol in the
synthesis. While samples 65S20Fe and 60S20Fe have much
higher magnetizations than that of sample 65S10Fe, all the
bioactive glass scaffolds similarly exhibit a linear increase
of magnetizations in the low field regime. The slope of
changing magnetization is gradually reduced beyond 5
kOe, but saturation is not obtained under the maximum
magnetic field of 10 kOe. When the applied magnetic field
is decreased back to 0 kOe, each magnetization curve is
virtually traced back to the same path. The minimal
hysteresis and coercive field are characteristics of super‐
paramagnetism. In these bioactive glass scaffolds, the
superparamagnetic behaviour is attributed to iron oxide
nanoparticles whose sizes are in the single-domain regime.
From structural  analysis  of  iron oxides by XANES,  the
overall  characteristics  of  XANES  spectra  in  Figure  2,
including the pre-edge, are similar for all four bioactive
glass  scaffolds.  Each  spectrum  is  compared  with  four
standards, namely FeO, Fe3O4, α-Fe2O3 and γ-Fe2O3. Since
the spectra of bioactive glass scaffolds are not identical to
any single standard, the iron oxides are decidedly in the
mixed  phase.  The  pre-edge  match  further  suggests  a
majority  of  Fe3+.  The corundum-structured α-Fe2O3  and
spinel-structured γ-Fe2O3  are therefore used in the LCF
fitting and the simulated spectra are plotted in dotted lines
for comparison. The fitting is very good up to 7125 eV,
whereas the discrepancy at higher energy is likely to be
due to the presence of Fe3O4  and the self-absorption in
fluorescence spectra. While α-Fe2O3 is the dominant phase
in samples 65S10Fe and 65S15Fe, the XANES fits indicate
that samples 65S20Fe and 60S20Fe have a higher propor‐
tion of γ-Fe2O3. Such preference of γ-Fe2O3 over α-Fe2O3
enhances the magnetization in these samples, as previous‐
ly shown in Figure 1. The reduction in the intensity and
width of the absorption peak in Figures 2(c) and 2(d) can
also be explained by the increase in the γ-Fe2O3 proportion.
According to an FESEM image in Figure 3(a), the 3DOM
structure is inherited from the PMMA template during the
sol-gel synthesis and the network of hexagonal pores is
extended over the piece of scaffold. However, the skeletal
walls are increasingly distorted by the rise of the magnetic
phase in Figures 3(b)-3(d). In addition to the wall distortion,
a high molar ratio of Fe apparently disrupts the arrange‐
ment of the template during the synthesis and leads to the
subsequent collapse of the porous network. After soaking
in SBF solutions for half a day, the bone-like apatite starts
to form on the walls in sample 65S15Fe. By tracking surface
changes for up to five days (Figure 4), it can be seen that the
bone-like apatite phase increases with the increased
soaking time until the porous surfaces are fully covered.
The bioactivity is increased by the rise in the magnetic
phase as the bone-like apatite is formed with a smaller grain
and a higher rate (Figure 5). The surface of sample 60S20Fe
is densely packed with fine grains after only one day. This
increased bioactivity is linked to the biocompatibility of the
γ-Fe2O3 phase present in this sample [21–23]. While the
Figure 1. Magnetization curves showing superparamagnetic behaviours of samples 65S10Fe, 65S15Fe, 65S20Fe and 60S20Fe
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addition of the magnetic phase may be detrimental to
bioactivity in bioactive glasses, this finding demonstrates
that the bioactivity can be improved by promoting the γ-
Fe2O3 phase [11].
Figure 3. FESEM images showing porous networks in samples (a) 65S10Fe,
(b) 65S15Fe, (c) 65S20Fe and (d) 60S20Fe
Figure 4. FESEM images showing the successive growth of the apatite phase
on samples 65S15Fe after soaking in SBF solution for 0.5, 1, 3 and 5 days
Figure 5. FESEM images showing the successive growth of the apatite phase
on samples 60S20Fe after soaking in SBF solution for 0.5, 1, 3 and 5 days
Figure 6. XRD patterns showing the structural phase in samples 65S15Fe
and 60S20Fe after soaking in SBF solution for 3 and 7 days
After soaking in SBF solution for three and seven days,








Figure 2. XANES spectra of samples (a) 65S10Fe, (b) 65S15Fe, (c) 65S20Fe and (d) 60S20Fe compared with LCF fits by α-Fe2O3 and γ-Fe2O3 standards
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teristic XRD peaks (Figure 6). The appearance of patterns
is related to the amorphous silicate phases [8, 13]. Whereas
the crystalline phases are not identified by XRD, the EDS
spectra indicate the composition of Fe among the common
bioactive glass elements, i.e., Si, Ca, Na, P, and O. As
compared with Figure 7, the reaction of apatite forming
between three and seven days of soaking in SBF solutions
changes the compositions. The decreases in Ca and Na are
due to the reaction of ion exchanges, with the substantial
increase in P signifying the formation of bone-like apatite
[3]. Nevertheless, Fe remains fairly constant, at around
18%wt. in sample 60S20Fe.
4. Conclusions
Magnetic macro/mesoporous bioactive glasses with a
potential application in bone cancer treatments were
derived by one-pot sol-gel synthesis. The increase in
Fe(NO3)3 9H2O as the starting reagent from 10 to 20% mol
enhanced the magnetization of the bioactive glass scaf‐
folds. According to synchrotron XANES analysis, the
superparamagnetic properties were due to the mixed iron
oxide phase. Different contributions of α-Fe2O3 and γ-
Fe2O3 also led to different rates in the formation of bone-
like apatite in the SBF. Such bioactivity was apparent in the
changes in surface images and elemental compositions. The
variation in bioactivity and magnetic properties of these
porous bioactive glass scaffolds were explained in terms of
the differences between α-Fe2O3 and γ-Fe2O3 properties.
5. Acknowledgements
This work is financially supported by Shell Centennial
Education Fund, Shell Companies in Thailand. XRD was
characterized by Payoon Senthongkaew of Kasetsart
University. FESEM images were obtained at University of
Technology Sydney, Australia.
6. References
[1] Gao C, Deng Y, Feng P, Mao Z, Li P, Yang B, Deng J,
Cao Y, Shuai C, Peng S (2014) Current progress in
bioactive  ceramic  scaffolds  for  bone  repair  and
regeneration. Int. J. Mol. Sci. 15:4714–4732.
[2] Gerhardt J L C, Boccaccini A R (2010) Bioactive glass
and glass-ceramic scaffolds for bone tissue engi‐
neering. Materials. 3:3867–910.
[3] Wu C, Chang J (2012) Mesoporous bioactive glasses:
Structure characteristics, drug/growth factor
delivery and bone regeneration application.
Interface Focus. 2:292–306.
[4] Izadi S, Hesaraki S, Hafezi-Ardakani M (2015)
Production of bioactive glass-derived scaffolds
using citric acid porogen. Int. J. Mater. Res. 106:301–
306.
[5] Kamalian R, Yazdanpanah A, Moztarzadeh F,
Ravarian R, Moztarzadeh Z, Tahmasbi M, Mozafari
M (2012) Synthesis and characterization of bioactive
glass/forsterite nanocomposites for bone and dental
implants. Ceram.-Silikaty. 56:331–340.
[6] Hashmi MU, Shah SA, Umer F, Alkedy AS (2013)
Effect of sintering temperature on microstructure
and in vitro behavior of bioactive glass-ceramics.
Ceram.-Silikaty. 57:313–318.
[7] Shankhwar N, Singh R K, Kothiyal G P, Perumal A,
Srinivasan A (2014) Evolution of magnetic proper‐
ties of CaO-P2O5–Na2O-Fe2O3–SiO2 glass upon heat
treatment. IEEE Trans. Magn. 50:4003504.
[8] Wang D, Lin H, Jiang J, Han X, Guo W, Wu X, Jin Y,
Qu F (2013) One-pot synthesis of magnetic, macro/
mesoporous bioactive glasses for bone tissue
engineering. Sci. Technol. Adv. Mater. 14:025004.
[9] Wu C, Fan W, Zhu Y, Gelinsky M, Chang J, Cuni‐
berti G, Albrecht V, Friis T, Xiao Y (2011) Multifunc‐
tional magnetic mesoporous bioactive glass
scaffolds with a hierarchical pore structure. Acta
Biomater. 7:3563–3572.
[10] Jayalekshmi A C, Victor S P, Sharma C P (2013)
Magnetic and degradable polymer/bioactive glass
composite nanoparticles for biomedical applica‐
tions. Colloids Surf. B: Biointerfaces. 101:196–204.
[11] Li X, Wang X, Hua Z, Shi J (2008) One-pot synthesis
of magnetic and mesoporous bioactive glass
composites and their sustained drug release
property. Acta Mater. 56:3260–3265.
Figure 7. EDS spectra comparing elemental compositions in sample 60S20Fe after soaking in SBF solution for (a) 3 and (b) 7 days
5Thanida Charoensuk, Wanwisa Limphirat, Chitnarong Sirisathitkul, Witoon Tangwatanakul, Pongsakorn Jantaratana and Upsorn Boonyang:
Synchrotron X-ray Absorption and In Vitro Bioactivity of Magnetic Macro/Mesoporous Bioactive Glasses
[12] Li G, Feng S, Zhou D (2011) Magnetic bioactive glass
ceramic in the system CaO-P2O5-SiO2-MgO-CaF2-
MnO2-Fe2O3 for hyperthermia treatment of bone
tumor. J. Mater. Sci.: Mater. Med. 22:2197–2206.
[13] Zhu M, Zhang J, Zhou Y, Liu Y, He X, Tao C, Zhu Y
(2013) Preparation and characterization of magnetic
mesoporous bioactive glass/carbon composite
scaffolds. J. Chem. 2013: 893479.
[14] Baikousi M, Agathopoulos S, Panagiotopoulos I,
Georgoulis A D, Louloudi M, Karakassides M A
(2008) Synthesis and characterization of sol–gel
derived bioactive CaO–SiO2–P2O5 glasses contain‐
ing magnetic nanoparticles. J. Sol-Gel Sci. Technol.
47:95–101.
[15] Singh R K, Kothiyal G P, Srinivasan A (2009) In
vitro evaluation of bioactivity of CaO–SiO2–P2O5–
Na2O–Fe2O3 glasses. Appl. Surf. Sci. 255:6827–6831.
[16] Singh R K, Srinivasan A (2011) Magnetic properties
of bioactive glass-ceramics containing nanocrystal‐
line zinc ferrite. J. Magn. Magn. Mater. 323:330–333.
[17] Leventouri T, Kis A C, Thompson J R, Anderson I
M (2005) Structure, microstructure, and magnetism
in ferrimagnetic bioceramics. Biomaterials. 26:4924–
4931.
[18] Ravel B, Newville M (2005) Athena, Artemis,
Hephaestus: data analysis for X-ray absorption
spectroscopy using IFEFFIT. J. Synchrotron Rad.
12:537–541.
[19] Kokubo T, Takadama H (2006) How useful is SBF in
predicting in vivo bone bioactivity? Biomaterials.
27:2907–2915.
[20] Charoensuk T, Boonyang U, Sirisathitkul C,
Panchawirat P, Senthongkaew P (2014) Effect of sol-
gel ageing time on three dimensionally ordered
macroporous structure of 80SiO2-15CaO-5P2O5
bioactive glasses. Mater. Sci. Medzg. 20:97–102.
[21] Markides H, Rotherham M, El Haj A J (2012)
Biocompatibility and toxicity of magnetic nanopar‐
ticles in regenerative medicine. J. Nanomater.
2012:614094.
[22] Singh N, Jenkins G J S, Asadi R, Doak S H (2010)
Potential toxicity of superparamagnetic iron oxide
nanoparticles (SPION). Nano. Rev. 1:5358.
[23] Layek S, Pandey A, Pandey A, Verma H C (2010)
Synthesis of γ–Fe2O3 nanoparticles with crystallo‐
graphic and magnetic texture. Int. J. Eng. Sci.
Technol. 2:33–39.
[24] Cheng W, Tang K, Qi Y, Sheng J, Liu Z (2010) One-
step synthesis of superparamagnetic monodisperse
porous Fe3O4 hollow and core-shell spheres. J.
Mater. Chem. 20:1799–1805.
6 Nanomater Nanotechnol, 2015, 5:34 | doi: 10.5772/61994
